Abingdon Health PLC (ABDX) Price & Analysis

Compare

22 Followers

ABDX Stock Chart & Stats

6.25p

0.20p(2.50%)

At close: Jan 09 4:00 PM EST

6.25p

0.20p(2.50%)

Day’s Range― - ―

52-Week Range5.10p - 8.50p

Previous CloseN/A

Volume7.61K

Average Volume (3M)78.74K

Market Cap

£16.32M

Enterprise Value12.18M

Total Cash (Recent Filing)£1.92M

Total Debt (Recent Filing)£1.03M

Price to Earnings (P/E)―

Beta-0.05

Next Earnings

Apr 01, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding251,077,850

10 Day Avg. Volume45,332

30 Day Avg. Volume78,736

Financial Highlights & Ratios

PEG Ratio-0.06

Price to Book (P/B)4.84

Price to Sales (P/S)3.04

P/FCF Ratio-7.48

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSustained top-line expansion indicates strengthening product adoption and market penetration in diagnostics. Over 2-6 months this supports scale economies, improves bargaining power with suppliers and customers, and creates a platform to invest in R&D and commercial expansion without relying solely on financing.

Manageable LeverageLow leverage provides balance-sheet flexibility to fund working capital, product development, or absorb revenue cyclicality. It reduces solvency risk and preserves capacity for strategic partnerships or contract delivery, supporting operational continuity over the medium term.

Strategic Market PositionConcentration on rapid, point-of-care diagnostics aligns with durable healthcare trends toward decentralised testing and faster results. This structural demand supports recurring orders, partnership opportunities with providers and pharma, and long-term relevance of core products.

Bears Say

Profitability WeaknessPersistently negative margins indicate the business is not converting revenue into sustainable profits. Over months this constrains reinvestment capacity, pressures pricing or cost structure, and may necessitate operational restructuring or margin recovery to reach durable profitability.

Poor Cash ConversionNegative operating cash flow despite revenue growth signals weak cash conversion and working capital stress. This erodes liquidity and forces reliance on external financing or equity, increasing funding risk and potentially diluting returns over the medium term if cash generation isn't restored.

Negative Returns To EquityA negative ROE shows shareholder capital is not being profitably deployed. Over a 2-6 month horizon this questions management's ability to generate returns from investments and may limit investor confidence, making it harder to raise capital cheaply for growth or operations.

Abingdon Health PLC News

Abingdon Health lifts H1 revenues 45% and backs full-year guidance amid US expansion

Abingdon Health PLC ( ($GB:ABDX) ) has shared an update. Abingdon Health reported a 45% rise in first-half...

1M ago

Abingdon Health Names Cavendish as Sole Broker and Nominated Adviser

Abingdon Health PLC ( ($GB:ABDX) ) has provided an update. Abingdon Health plc, a specialist in rapid diagnostic...

1M ago

Abingdon Health Updates Share Capital Following Option Exercise

Abingdon Health PLC ( ($GB:ABDX) ) has issued an announcement. Abingdon Health plc, an international developer and manufacturer...

2M ago

Abingdon Health Secures European Patent for Innovative Smartphone-Based Diagnostics

Abingdon Health PLC ( ($GB:ABDX) ) has shared an announcement. Abingdon Health PLC has secured a European patent...

2M ago

Abingdon Health PLC Secures Strong Shareholder Support at AGM

An update from Abingdon Health PLC ( ($GB:ABDX) ) is now available. Abingdon Health PLC announced that all...

2M ago

Abingdon Health Updates LTIP with New Share Awards

Abingdon Health PLC ( ($GB:ABDX) ) just unveiled an announcement. Abingdon Health PLC announced updates to its Long...

3M ago

Abingdon Health PLC Announces AGM Date and Publishes 2025 Annual Report

Abingdon Health PLC ( ($GB:ABDX) ) just unveiled an announcement. Abingdon Health PLC has announced the date for...

3M ago

Abingdon Health Reports Strong Growth and Expansion in FY25 Results

Abingdon Health PLC ( ($GB:ABDX) ) has provided an announcement. Abingdon Health plc reported significant growth and expansion...

3M ago

Abingdon Health Secures $2M Contract for Multiplex Diagnostic Test Development

The latest update is out from Abingdon Health PLC ( ($GB:ABDX) ). Abingdon Health PLC has secured a...

3M ago

Abingdon Health Introduces Eco-Friendly Seaweed-Based Lateral Flow Test Housings

An announcement from Abingdon Health PLC ( ($GB:ABDX) ) is now available. Abingdon Health PLC has launched a...

4M ago

ABDX FAQ

What was Abingdon Health PLC’s price range in the past 12 months?

Abingdon Health PLC lowest share price was 5.10p and its highest was 8.50p in the past 12 months.

What is Abingdon Health PLC’s market cap?

Abingdon Health PLC’s market cap is £16.32M.

When is Abingdon Health PLC’s upcoming earnings report date?

Abingdon Health PLC’s upcoming earnings report date is Apr 01, 2026 which is in 38 days.

How were Abingdon Health PLC’s earnings last quarter?

Abingdon Health PLC released its earnings results on Nov 11, 2025. The company reported -0.002p earnings per share for the quarter, missing the consensus estimate of N/A by -0.002p.

Is Abingdon Health PLC overvalued?

According to Wall Street analysts Abingdon Health PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Abingdon Health PLC pay dividends?

Abingdon Health PLC does not currently pay dividends.

What is Abingdon Health PLC’s EPS estimate?

Abingdon Health PLC’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Abingdon Health PLC have?

Abingdon Health PLC has 251,077,850 shares outstanding.

What happened to Abingdon Health PLC’s price movement after its last earnings report?

Abingdon Health PLC reported an EPS of -0.002p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.143%.

Which hedge fund is a major shareholder of Abingdon Health PLC?

Currently, no hedge funds are holding shares in GB:ABDX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Abingdon Health PLC

Abingdon Health PLC (ABDX) is a UK-based company specializing in the development and manufacture of rapid diagnostic tests. The company focuses on providing innovative solutions in the healthcare sector, particularly in the fields of infectious diseases, including COVID-19 testing, and other point-of-care testing applications. Abingdon Health aims to enhance patient outcomes through its high-quality, reliable diagnostics that are designed for use in various settings, ranging from hospitals to home testing.